Omeros Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use In Nine Patients With Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy
Omeros Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use In Nine Patients With Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy
Omeros Corporation (NASDAQ:OMER) today announced the upcoming presentation of a report detailing narsoplimab treatment in nine adult patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA). Narsoplimab is Omeros' investigational antibody targeting MASP-2, the effector enzyme of the lectin pathway of the complement system.
歐美羅斯公司（納斯達克股票代碼：OMER）今天宣佈即將發佈一份報告，詳細介紹納索普利單抗對九名造血幹細胞移植相關血栓性微血管病（TA-TMA）成年患者的治療。Narsoplimab 是奧美羅斯的研究性抗體，靶向 MASP-2，補體系統凝集素途徑的效應酶。
The report was authored by an external group of U.S. investigators involved in the treatment of these patients with narsoplimab provided under Omeros' compassionate use program. It will be featured as a poster presentation at the 2024 Tandem Meetings – the Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy and the Center for International Blood and Marrow Transplant Research, to be held February 21-24, 2024 in San Antonio, Texas.
該報告由參與根據Omeros的同情使用計劃提供的納索普利單抗治療這些患者的外部美國研究人員撰寫。它將在2024年2月21日至24日在德克薩斯州聖安東尼奧舉行的2024年串聯會議——美國移植與細胞療法學會和國際血液和骨髓移植研究中心的移植與細胞療法會議上以海報形式展出。
The poster will be presented by Lindsay Adkins, MSN, FNP-BC, BMTCN, of the Sarah Cannon Transplant and Cellular Therapy Program, Nashville, Tennessee. Details of the presentation are as follows:
該海報將由田納西州納什維爾莎拉·坎農移植和細胞療法計劃的MSN、FNP-BC、BMTCN的林賽·阿德金斯發佈。演示詳情如下：
Real-World Experience with Narsoplimab (OMS721) for the Treatment of Transplant-Associated Thrombotic Microangiopathy (Poster #186)
Poster Session: Acute Regimen-Related Toxicity and Supportive Care
Date: Thursday, February 22, 2024
Presentation Time: 6:45 - 7:45 p.m. CST
Location: Exhibit Hall 4A
使用納索普利單抗 (OMS721) 治療移植相關血栓性微血管病的真實經驗（海報 #186）
海報發佈會: 急性療法相關毒性和支持性護理
日期: 2024 年 2 月 22 日，星期四
演示時間: 美國中部標準時間下午 6:45-7:45
地點: 4A 展廳
The presentation abstract is available now on the Tandem Meetings website at the following link:
演示摘要現已在Tandem Meetings網站上發佈，鏈接如下：
The poster is expected to be made available on Omeros' website at shortly after the meeting presentation.
預計該海報將在會議演示後不久在Omeros的網站上公佈。